Posted by Michael Wonder on 29 Jun 2022
Reimbursement price of GERD drug Fexclu finalised at $0.73
29 June 2022 - The Ministry of Health and Welfare’s health insurance policy committee set the reimbursement price of Fexclu (fexuprazan), a treatment for gastro-oesophageal reflux disease developed by Daewoong Pharmaceutical, at 939 won ($0.73) per tablet.
Fexclu is the nation’s 34th novel medicine.
